28 reports

EXECUTIVE SUMMARY ##.

  • Prescription Drug
  • APAC
  • World
  • Market Size
  • PRESCRIPTION DRUGS PRODUCTION AND DEMAND
  • Prescription Drugs Markets Outlook Overview

After twenty years' rapid development, China' s prescription drugs market has become one of the largest prescription drugs markets in the world.

  • Prescription Drug
  • China
  • Demand
  • Supply
  • Zhejiang Expressway Co., Ltd.
  • III. PRESCRIPTION DRUGS INDUSTRY ASSESSMENTS
  • III. PRESCRIPTION DRUGS INDUSTRY ASSESSMENTS

After twenty years' rapid development, China' s prescription drugs market has become one of the largest prescription drugs markets in the world.

  • Prescription Drug
  • China
  • Supply
  • Tongrentang Group
  • Zhejiang Expressway Co., Ltd.
  • IV. PRESCRIPTION DRUGS PRODUCTION AND DEMAND
  • IV. PRESCRIPTION DRUGS PRODUCTION AND DEMAND

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for prescription drugs in China is growing rapidly.

  • Pharmaceutical
  • Prescription Drug
  • Therapy
  • China
  • Demand

Anti-Obesity Prescription Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026 ##.

  • Prescription Drug
  • World
  • Demand
  • Market Shares
  • Market Size
  • 8.2 MORE EFFICACIOUS PRESCRIPTION DRUGS INDICATED FOR IBS
  • OUTLINES THE SALES FOR IBS PRESCRIPTION DRUGS IN THE US IN 2016 AND 2026.

pg=##.

  • Prescription Drug
  • Allergan plc
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Ironwood Pharmaceuticals, Inc.

Merck & Co

2631 3000 2340

Snapshot Overview – Merck and Co’s prescription pharmaceutical sales will increase at a sluggish CAGR of ##. ##% out to 2027.

  • Prescription Drug
  • Demand

Key themes – [##] PharmaVitae expects Shire’s prescription pharmaceutical sales to grow at a ##. ##% CAGR between 2017–## [##] Shire’s CNS portfolio will increase to $##. ##bn in 2022, but then fall sharply to $##. ##bn in 2027 due to generic erosion of Vyvanse sales in the US [##] Shire’s mar

  • Prescription Drug
  • Demand

GlaxoSmithKline

2631 3000 2340

Main themes – [##] HIV strategy is evolving due to competition [##] The company has placed its hopes on new launches Shingrix and Trelegy Ellipta.

  • Prescription Drug
  • Demand

Eli Lilly

2631 3000 2340

Key themes – [##] Diabetes growth will be restricted by external GLP-## competition and insulin price caps [##] Eli Lilly’s CNS portfolio will be the company’s greatest growth driver [##] Olumiant’s regulatory issues will hamper growth out to 2027.

  • Prescription Drug
  • Demand

Lundbeck

2631 3000 2340

Snapshot Overview – Lundbeck’s prescription pharmaceutical sales are forecast to grow at a ##. ##% CAGR over the forecast period.

  • Prescription Drug
  • Demand
  • Prescription Drugs and Medical Insurance are the Areas of Focus for Retail Giants
  • 3.4 Alibaba Aims to Deepen Presence in O2O Prescription Drug Services

http:/ / mic. iii. org. tw/ intelligence FIGURE ## RETAIL GIANTS' STRATEGIES FOR HEALTHCARE MARKET EXPANSION LIST OF FIGURES TABLE ## OVERVIEW OF M& AS OF INTERNAT IONAL RETAIL GIANTS TABLE ## SELF-OPERATED HEALTHCARE SERVICE OF AMAZON AND WALGREENS TABLE ## RETAIL BRA

  • Prescription Drug
  • United States
  • Market Size
  • CVS Caremark Corporation
  • Walgreens Boots Alliance, Inc.

## STRATEGY ANALYSIS ## Background ## Acquisition strategy ## Biosimilars ## Amgen’s SWOT analysis ## Amgen’s key upcoming catalysts ## PORTFOLIO ANALYSIS ## 2018 ## 2017 ## FACTS AND FIGURES ## Amgen’s prescription pharma sales outlook ## Amgen’s regional pharma sales outlook ##

  • Prescription Drug
  • Demand

Teva

2631 3000 2340

prescription pharma sales outlook ## Teva’s regional pharma sales outlook ## Teva’s therapy area dynamics ## Teva’s growth drivers and resistors ## Teva’s lifecycle analysis ## Teva’s MandA strategy and history ## BIBLIOGRAPHY LIST OF FIGURES ## Figure ##: Teva’s

  • Prescription Drug
  • Demand

During 2016–##, Merck KGaA’s prescription pharmaceutical sales are forecast to grow by $##m as it shifts focus to Bavencio and its oncology portfolio.

  • Prescription Drug
  • Demand
  • Market Size

Highlights Bayer’s prescription drug sales will experience modest growth up to 2026.

  • Prescription Drug
  • Demand

Q## 2017 regulatory update COMPANY CONTEXT AbbVie split from Abbott Humira Amgen-AbbVie settlement Future revenue streams Commercial strategy AbbVie’s SWOT analysis AbbVie’s key events and catalysts FACTS AND FIGURES AbbVie’s prescription pharma sales outlook AbbVie’s regional pharma sales o

  • Prescription Drug
  • Demand

##: Pharmaceutical share of total healthcare spending in the US, Canada, and the five major EU markets ## Table ##: Per capita pharmaceutical spending in the US, Canada, and the five major EU markets ## Table ##: Pharmaceutical share of total healthcare spending in the US, 2000–## ## Table ##:

  • Pharmaceutical
  • Prescription Drug
  • United States

Highlights Shionogi’s prescription pharmaceutical sales are forecast to achieve modest growth.

  • Prescription Drug
  • Market Shares

Highlights Big Pharma prescription drug sales are forecast to grow to $##bn by 2026 at a compound annual growth rate of ##. ##% Number one company in 2021: Pfizer sustains top ranking in prescription drug sales out to 2021 Number one company in 2026: Roche out-perfo

  • Pharmaceutical
  • Prescription Drug
  • Demand

INTRODUCTION.............. ## ##.

  • E-Healthcare
  • Healthcare IT
  • Prescription Drug
  • United States
  • Market Shares
  • FEB 07, 2017: MONOSOL RX RECEIVES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR TADALAFIL PHARMFILM
  • LICENSING AGREEMENTS

The Tadalafil OSF NDA has been assigned a Prescription Drug User Fee Act (PDUFA) target action date of September ##, 2017.

  • Prescription Drug
  • Therapy
  • United States
  • Company
  • MonoSol Rx, LLC
  • Summary 1 Full name of company:
  • COMPANY BACKGROUND

This is due to its primary focus being on Rx medicines, which cannot be advertised in Georgia.

  • OTC
  • Prescription Drug
  • Georgia
  • Demand
  • Supply
  • FEB 07, 2017: MONOSOL RX RECEIVES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR TADALAFIL PHARMFILM
  • LICENSING AGREEMENTS

The Tadalafil OSF NDA has been assigned a Prescription Drug User Fee Act (PDUFA) target action date of September ##, 2017.

  • Prescription Drug
  • Therapy
  • United States
  • Company
  • MonoSol Rx, LLC
  • FEB 07, 2017: MONOSOL RX RECEIVES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR TADALAFIL PHARMFILM
  • LICENSING AGREEMENTS

The Tadalafil OSF NDA has been assigned a Prescription Drug User Fee Act (PDUFA) target action date of September ##, 2017.

  • Prescription Drug
  • Therapy
  • United States
  • Company
  • MonoSol Rx, LLC

Specifically, we are asking endocrinologists… Which prescription pharmaceutical, diabetes-specialist, provides you with the most comprehensive and satisfactory approach in terms or product detailing/ MSL engagement?

  • Diabetes
  • Insulin
  • Prescription Drug
  • United States
  • Market Size

The company offers a narrow range within consumer health but a considerably wider range of generics within Rx medicines.

  • OTC
  • Prescription Drug
  • Algeria
  • United States
  • Demand
  • China Prescription Drug Sales Market Size: 2008-2013
  • China Prescription Drug Sales Market Size: 2014-2024

Table ##. ##. ##. ## China Prescription Drug Sales Market Size: 2014-2024 Figure ##. ##. ##. ## China Prescription Drug Sales Market Size: 2014-2024 GMR forecasts that China prescription drug sales will increase to $##bn by 2024 from $##. ##bn in 2014; a ## year CAGR of ##. ##%.

  • Prescription Drug
  • China
  • East Asia
  • Market Size
  • Novo Nordisk Group